(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
through the SET Electronic Listed Companies Information Disclosure (ELCID) regarding the change in the use of proceeds from its capital fundraising by allocating 5.58 billion baht to a private placement and
compared to the same period last year. Table 1: Sales Revenue by Product Line for the Three Months Period Ended 31 December (YoY) Product Line/ Business Group Consolidated financial statements Change
expect the improvement after the pandemic of COVID-19 ends. Table 1 : Sales Revenue by Product Line for the Three Months ended 31 March (3M YoY) Sales by geography Consolidated financial statements Change
10.69% (189.69) (88.71%) 31 December 2019 31 December 2018 Change For the year ended Page 2 Revenue from Sale of real estate Revenue from sale of real estate for the year ended 31 December 2019 and 2018
online Consolidated Q1/ 2019 Q1/ 2018 Change Financial Statements (Million Baht) (%) (Million Baht) (%) (%) Revenue from Sales 1,321.9 100.0 % 1,322.2 100.0 % (0.0 %) Cost of Sales (938.8) (71.0 %) (958.7
million, whereas Baht 2.59 million in 2018, showing an decrease of Baht 0.83 million or 32.05 % decrease. Overall nearly the same, there is no significant change. Most of them are revenues from interests
increase in profit before income tax. Please be informed accordingly. Yours sincerely, (Assoc.Prof.Dr.Chalerm Harnphanich, M.D.) Chief Executive Officer Revenue Structure Q1/2019 Q1/2018 Change General
: Unit: Million Baht Revenue Structure Q2/2019 Q2/2018 Change General Patient Revenue 1,384.2 1,284.6 99.6 7.8% Social Security Scheme Revenue 752.8 633.3 119.5 18.9% Other Revenue 30.0 27.3 2.7 9.9% Total